Traws Pharma Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2011
Net Income	-18.95	-18.96	-16.16	-25.16	-21.5	-20.57	-24.09	-19.67	-23.98	-63.68	Upgrade
Depreciation & Amortization	0.02	0.01	0.01	0.01	0.01	0.06	0.09	0.1	0.15	0.43	Upgrade
Share-Based Compensation	1.3	1.17	0.58	0.37	1.05	1.15	1.71	3.93	3.79	5.07	Upgrade
Other Operating Activities	-0.3	1.48	-3.91	1.7	-0.39	-3.33	-1.53	-0.17	-11.2	0.53	Upgrade
Operating Cash Flow	-17.93	-16.29	-19.49	-23.08	-20.83	-22.7	-23.82	-15.81	-31.24	-57.65	Upgrade
Capital Expenditures	-0.01	0	0	-0.02	-0.06	0	0	0	0	-0.23	Upgrade
Change in Investments	0	0	0	0	0	0	0	0	0	40	Upgrade
Investing Cash Flow	-0.01	0	0	-0.02	-0.06	0	0	0	0	39.77	Upgrade
Share Issuance / Repurchase	0	0	55.56	19.36	26.61	35.66	6.36	17.42	7.46	0.96	Upgrade
Other Financing Activities	-	-	-	0	0.04	-	-	-	-	0.5	Upgrade
Financing Cash Flow	0	0	55.56	19.36	26.65	35.66	6.36	17.42	7.46	1.46	Upgrade
Exchange Rate Effect	0.01	-0.02	-0.03	0.03	-0.01	-0.02	0.03	-0.01	-0.01	-0.01	Upgrade
Net Cash Flow	-17.94	-16.31	36.05	-3.7	5.76	12.95	-17.43	1.6	-23.78	-16.43	Upgrade
Free Cash Flow	-17.95	-16.29	-19.49	-23.09	-20.89	-22.7	-23.82	-15.81	-31.24	-57.88	Upgrade
Free Cash Flow Margin	-7940.71%	-7209.73%	-8622.57%	-9995.67%	-956.76%	-1848.21%	-3026.68%	-285.12%	-272.68%	-7234.50%	Upgrade
Free Cash Flow Per Share	-0.85	-0.78	-1.16	-1.99	-21.78	-82.55	-595.48	-803.75	-3090.86	-6013.84	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).